Lalwani Nikhil 4
4 · ANI PHARMACEUTICALS INC · Filed Aug 14, 2025
Insider Transaction Report
Form 4
Lalwani Nikhil
DirectorPRESIDENT & CEO
Transactions
- Sale
Common Stock
[F1]2025-08-12$85.93/sh−56,960$4,894,573→ 411,219 total
Footnotes (1)
- [F1]The shares were sold in multiple trades at prices ranging from $84.40 to $87.47. The price reported above reflects the weighted average sales price.
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook|2025-08-14